The enigma of genetics etiology of atherosclerosis in the Post-GWAS era

Current Atherosclerosis Reports

Volumn 14, Issue 4, 2012, Pages 295-299

  Marian, A J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Genetics; GWAS; Polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; SORTILIN;

ARTICLE; BINDING SITE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CXC12 GENE; CYCLIN DEPENDENT KINASE 2A GENE; CYCLIN DEPENDENT KINASE 2B GENE; EPIGENETICS; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LAMIN A GENE; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM; SORTILIN 1 GENE;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865587531     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0245-0     Document Type: Article

References (22)

1. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-6. (Pubitemid 24106561)
2. Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol: Official Journal of the German Cardiac Society. 2007;96:1-7. (Pubitemid 46175364)
3. Marian AJ, Belmont J. Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ Res. 2011;108:1252-69. This review article will bring the readers up-To-date with the current approaches to genetic studies of complex diseases, such as atherosclerosis.
4. Farouk SS, Rader DJ, Reilly MP, Mehta NN. CXCL12: a new player in coronary disease identified through human genetics. Trends Cardiovasc Med. 2010;20:204-9.
5. Worman HJ, Bonne G. "Laminopathies": A wide spectrum of human diseases. Exp Cell Res. 2007;313:2121-33. (Pubitemid 46850729)
6. Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science. 2005;307:1072-9. (Pubitemid 40262106)
7. Dawson E, Abecasis GR, Bumpstead S, et al. A first-generation linkage disequilibrium map of human chromosome 22. Nature. 2002;418:544-8. (Pubitemid 34851401)
8. Ardlie KG, Kruglyak L, Seielstad M Patterns of linkage disequilibrium in the human genome. Nat Rev Genet. 2002;3:299-309. (Pubitemid 34279798)
9. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666-76.
10. Pirruccello J, Kathiresan S. Genetics of lipid disorders. Curr Opin Cardiol. 2010;25:238-42.
11. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-9. This is a genome-wide association study that describes identification of multiple loci associated with systemic arterial hypertension and shows that the effect of each locus is very small.
12. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS genetics 2011; 7:e1002260.
13. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488-91. (Pubitemid 46906617)
14. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491-3. (Pubitemid 46906618)
15. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-53. (Pubitemid 47204873)
16. Collado M, Blasco MA, Serrano M Cellular senescence in cancer and aging. Cell. 2007;130:223-33. (Pubitemid 47081143)
17. Visel A, Zhu Y, May D, et al. Targeted deletion of the 9p21 noncoding coronary artery disease risk interval in mice. Nature. 2010;464:409-12. This is an interesting study that analyzes phenotypic consequences of deletion of the 9p21 analogous locus in mice and shows enhanced smooth muscle cell proliferation.
18. Harismendy O, Notani D, Song X, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature. 2011;470:264-8. This study provides mechanistic data to explain association of the 9p21 locus with coronary atherosclerosis. The findings are notable for enhanced interferon gamma response of expression of an anti-sense RNACDKN2B-AS1 in the presence of the risk allele. The latter leads to suppression of cell cycle regulator CDKN2B and hence, anticipated increased proliferation of smooth muscle cells.
19. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714-9. This study identifies SORT1, coding for Sortilin 1, as the gene associated with coronary atherosclerosis in the GWAS. The authors perform a series of in vivo and in vitro mechanistic studies and discover that the risk alleles generate a binding site for C/EBP-A and increased expression of Sort1 is associated with lower plasma LDL-C level.
20. Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213-23. The authors study the mechanism by which Sort1 influences plasma LDL-C level and report that over-expression of Sort1 is associated with increased hepatic release of lipoproteins and plasma LDL level, a finding that seems to be in contrast to the study by Musunuru et al. [19••].
21. Marian AJ. Molecular genetic studies of complex phenotypes. Transl Res. 2012;159:64-79.
22. Marian AJ. Elements of missing heritability. Curr Opin Cardiol. 2012;27.